NFL Biosciences SAS (ALNFL) — Cash Flow Reinvestment Rate
Latest as of June 2023:
0.00x
NFL Biosciences SAS (ALNFL) has a Cash Flow Reinvestment Rate of 0.00x as of June 2023, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €57.51K. See how leveraged is NFL Biosciences SAS's balance sheet to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€57.51K
EUR
Capital Expenditures
€0.00
EUR
NFL Biosciences SAS Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for NFL Biosciences SAS across 3 annual periods. Also explore ALNFL asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NFL Biosciences SAS (2020–2022)
Year-by-year capital reinvestment analysis for NFL Biosciences SAS. For live market cap and broader valuation context, see ALNFL market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | €0.00 | €104.89K | €0.00 | — |
| 2021 | 0.00x | €0.00 | €87.00K | €0.00 | — |
| 2020 | 0.00x | €0.00 | €83.91K | €0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow